Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Washington Marriott Wardman Park

Feb 18, 2015 8:00 AM - Feb 19, 2015 5:00 PM

2660 Woodley Road, NW, , Washington, DC 20008 , USA

Marketing Pharmaceuticals 2015: Drug/Device Marketing in an Evolving Environment

Overview

Although Washington DC is experiencing inclement weather, the Marketing Pharmaceuticals Conference will proceed as scheduled.  We look forward to seeing everyone in DC. 

Tutorial:  February 17
OPDP/APLB and Compliance 101: A Primer

Conference: February 18-19 


 

This conference will explore drug and device marketing in an evolving environment while serving as a vital forum for all stakeholders involved with the marketing, advertising, and promotion of a wide range of health care products.  The importance of understanding the complex regulations regarding the marketing of pharmaceuticals, veterinary products, biologics, and medical devices has never been higher.  Recent actions by the FDA in response to rapidly expanding technologies have left organizations behind in their compliance efforts. 

To understand these recent enforcement actions, this conference features sessions led by those heavily involved in the regulation of marketing pharmaceuticals.  These sessions will offer insight into avoiding regulatory pitfalls while serving as a neutral forum to ask questions.   

Featured

Want to learn more about Marketing Pharmaceuticals 2015: Drug/Device Marketing in an Evolving Environment? You've come to the right site!

Continuing-Education

Exhibits

Who should attend?

Professionals in pharmaceutical, biologics, veterinary drug and medical device companies involved in:

  • Compliance 
  • Corporate Communications
  • Legal 
  • Marketing 
  • Medical Information and Affairs 
  • Public Relations
  • Regulatory Affairs 
  • Senior Management

Learning objectives

At the conclusion of this meeting, participants should be able to:

  • Identify the trends reflected in the latest enforcement actions and policies issued by the FDA
  • Compare how other companies are complying with government regulatory requirements
  • Discuss best review and approval practices with industry colleagues
  • Assess novel promotional tactics trending in the pharmaceutical industry
  • Identify emerging issues in the oversight of marketing materials

Short Course or Primer

To keep you at the forefront.

Feb 17, 2015

OPDP/APLB and Compliance 101:

A Primer

Program Committee

  • Thomas W. Abrams, MBA, RPh
    Thomas W. Abrams, MBA, RPh Retired, Director, Office of Prescription Drug Promotion, OMP, CDER
    Former FDA, United States
  • Glenn N. Byrd, MBA
    Glenn N. Byrd, MBA President
    GByrd Ad-Promo Solutions, LLC, United States
  • Dale  Cooke, JD, MA
    Dale Cooke, JD, MA President
    PhillyCooke Consulting , United States
  • Mark  Gaydos
    Mark Gaydos Global Head, Advertising & Promotion, Global Regulatory Affairs
    Sanofi, United States
  • Lynette  Hopkinson
    Lynette Hopkinson Vice President, Commercial Regulatory Affairs, Global Regulatory Affairs
    Vertex Pharmaceuticals Incorporated, United States
  • John T. Murray
    John T. Murray President
    Grayscale Compliance LLC, United States
  • Wayne  Pines
    Wayne Pines President, Health Care
    United States
  • Lucy  Rose, MBA
    Lucy Rose, MBA President
    Lucy Rose and Associates, United States
  • Kristina  Vlaovic, MPH
    Kristina Vlaovic, MPH Vice President, Regulatory, Safety and Pharmacovigilance
    HALOZYME Inc., United States

Digital Learning Catalog

DIA Learning: eLearning Soultions
Download

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.